NVO Reports Strong Phase III Diabetes Data for Children & Adolescents

Novo Nordisk reports phase III teen study success for oral semaglutide, showing strong HbA1c reduction and paving the way for the first oral GLP-1 for youth.

Drugmaker to seek FDA approval of Ozempic pill for diabetic kids

Novo Nordisk said Thursday it will seek federal approval to expand the use of its Ozempic and Rybelsus pills to kids and ...
Pharmabiz

Telangana DCA cracks down on weight-loss drug violations, 75 medical shops face action

Telangana DCA cracks down on weight-loss drug violations, 75 medical shops face action: Our Bureau, Chennai Friday, April 24, 2026, 11:15 Hrs [IST] The Drugs Control Administratio ...
Hosted on MSN

Novo Nordisk reports Ozempic pill success in adolescent trial

Novo Nordisk’s Phase 3a PIONEER TEENS trial found that oral semaglutide significantly lowered blood sugar in adolescents with type 2 diabetes compared with placebo and was well tolerated. The company ...
ZAPZEE on MSN

5 celebrities whose extreme transformations started the 'Ozempic face' talk

Hollywood’s weight-loss drug conversation has officially moved from bodies to faces. The term “Ozempic face” is used for the ...
BioPharma Dive

Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics

Lilly shares dipped, and Novo’s climbed, as Foundayo’s early trajectory diverged from that of oral Wegovy. Elsewhere, Regeneron inked a drug price deal and two companies announced leadership changes.